Core Viewpoint - The collaboration between Rhein Biotech and Defo Capital is driven by a shared vision for the natural health ingredients sector and mutual recognition of strategic alignment [1] Group 1: Strategic Alignment - Both Defo Capital and Rhein Biotech have a strong belief in the potential of the natural health ingredients niche, which forms the foundation for their partnership [1] - The strategic alignment and shared philosophy between the two entities are key drivers for the collaboration [1] Group 2: Comprehensive Advantages - Rhein Biotech has over 20 years of industry experience, which contributes to its strong market position and comprehensive advantages that Defo Capital considered [1] - The company has a well-established industrial layout, sufficient production capacity, leading production technology, and a robust quality control system [1] - Rhein Biotech's global sales network and solid governance structure provide a strong foundation for its development [1] Group 3: Product Development Capabilities - The company possesses systematic capabilities in product selection, expansion, and incubation, supported by a complete R&D and industrialization chain [1] - This capability allows for efficient transformation of products from concept to market [1] Group 4: Technological Advancement - Rhein Biotech demonstrates a strong internal drive for business upgrades and technological iteration, maintaining a keen awareness of technological advancements [1] - The company has proactively engaged in cutting-edge fields such as synthetic biology and formulation applications, successfully achieving technological upgrades [1] - Rhein Biotech is actively exploring diverse application scenarios, including animal feed and pet nutrition, showcasing its growth potential and vitality [1]

Core Viewpoint - The collaboration between Rhein Biotech and Defo Capital is driven by a shared strategic vision and mutual recognition of the potential in the natural health ingredients sector [1] Group 1: Strategic Alignment - Both Defo Capital and Rhein Biotech have a strong belief in the natural health ingredients niche, which forms the foundation of their partnership [1] - The strategic alignment and shared philosophy between the two entities are key drivers for the collaboration [1] Group 2: Comprehensive Advantages - Rhein Biotech has over 20 years of industry experience, establishing a solid industry position and comprehensive advantages that attracted Defo Capital [1] - The company boasts a well-rounded industrial layout, robust production capacity, leading production technology, and a global sales network, ensuring a strong operational foundation [1] - Rhein Biotech possesses systematic capabilities in product selection, development, and incubation, enabling efficient transformation from concept to market [1] Group 3: Continuous Business Upgrades - The company demonstrates an internal drive for continuous business upgrades and technological iterations, maintaining a keen awareness of technological advancements [1] - Rhein Biotech has proactively ventured into cutting-edge fields such as synthetic biology and formulation applications, successfully achieving technological upgrades [1] - The company is actively exploring diverse application scenarios, including animal feed and pet nutrition, showcasing its growth vitality and potential [1]